Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Prepaid Assets (2016 - 2025)

Dare Bioscience (DARE) has disclosed Prepaid Assets for 8 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets fell 52.84% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, down 52.84%, and an annual FY2023 reading of $6.1 million, down 8.22% over the prior year.
  • Prepaid Assets was $1.5 million for Q3 2025 at Dare Bioscience, up from $1.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.1 million in Q2 2023 and bottomed at $201385.0 in Q1 2023.
  • Average Prepaid Assets over 5 years is $3.7 million, with a median of $2.9 million recorded in 2021.
  • The sharpest move saw Prepaid Assets plummeted 97.03% in 2023, then soared 2290.49% in 2024.
  • Year by year, Prepaid Assets stood at $2.5 million in 2021, then soared by 169.16% to $6.7 million in 2022, then fell by 8.22% to $6.1 million in 2023, then plummeted by 47.78% to $3.2 million in 2024, then crashed by 52.84% to $1.5 million in 2025.
  • Business Quant data shows Prepaid Assets for DARE at $1.5 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.